Creative Planning’s Alto Neuroscience ANRO Stock Holding History

Creative Planning’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$500K	Buy	+19,577	New	+$588K	﹤0.01%	3288

Other funds holding ANRO

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $798M AUM 22.92% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Revisor Wealth Management Akron, Ohio $404M AUM 18.59% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Creative Planning's ANRO Position: Q3 2026 in Review

Creative Planning opened a new position in Alto Neuroscience (ANRO) in Q3 2026: 19,577 shares worth $500K. The stake represents ﹤0.01% of the portfolio and ranks #3288 among its holdings.

26 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

Creative Planning held 19,577 shares of Alto Neuroscience worth $500K as of Q3 2026.
Alto Neuroscience was a new Creative Planning position in Q3 2026.
Alto Neuroscience made up ﹤0.01% of Creative Planning's portfolio in Q3 2026, its #3288 holding.
26 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.